Formation Bio is a pharmaceutical company revolutionizing drug development through a technology-driven platform that accelerates clinical trials. Founded in 2016, the company aims to address the bottlenecks in the drug development process by leveraging advancements in AI and innovative methodologies to significantly reduce the time and cost associated with bringing new treatments to market. Formation Bio licenses and develops clinical-stage drug assets internally, expediting their progression and driving efficiency in clinical trials. The company's efforts have resulted in a marked increase in the speed of drug delivery, with the potential to bring life-saving therapies to patients 1-3 years earlier than traditional methods. With a focus on transforming patient care across various therapeutic areas, Formation Bio fosters a collaborative culture where employees are encouraged to contribute to its mission of accelerating access to new medicines.